DBD vs EVCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

DBD

48.5
AI Score
VS
DBD Wins

EVCM

42.0
AI Score

Investment Advisor Scores

DBD

49score
Recommendation
BUY

EVCM

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DBD EVCM Winner
Forward P/E 12.6422 10.989 EVCM
PEG Ratio 0 0.3662 Tie
Revenue Growth 5.2% 2.7% DBD
Earnings Growth -82.9% 16.3% EVCM
Tradestie Score 48.5/100 42.0/100 DBD
Profit Margin 2.0% 5.7% EVCM
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD DBD

Relative Price Performance (Last 90 Days)

DBD 1M: -9.4% · 3M: -20.1% EVCM 1M: -24.2% · 3M: -29.4%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 38

RSI (14): 38.3 · Price: $57.34

EVCM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.8%), weak momentum, RSI 26

RSI (14): 26.0 · Price: $7.04

Fundamentals Snapshot

Metric DBD EVCM
Market Cap — —
Forward P/E 9.3 10.3
Trailing P/E 28.5 50.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.8%
Operating Margin 0.1% 0.1%
EPS 2.11 0.16
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.